Bristol Myers Squibb (BMY) Current Deferred Tax Assets (2009 - 2015)

Bristol Myers Squibb has disclosed Current Deferred Tax Assets across 7 years of filings, most recently posting $1.7 billion for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 14.64% year-over-year to $1.7 billion; the TTM figure through Sep 2015 stood at $1.7 billion (up 14.64% YoY), while the FY2014 annual figure was $1.6 billion, down 3.35% from the prior year.
• Current Deferred Tax Assets slipped to $1.7 billion in Q3 2015, from $1.9 billion in the prior quarter.
• Over the last five years, Current Deferred Tax Assets for BMY reached as high as $2.0 billion in Q3 2013 and fell as low as $1.1 billion in Q2 2011.
• The 5-year median for Current Deferred Tax Assets is $1.5 billion (2014), against an average of $1.5 billion.
• Annual changes were most pronounced in 2013 — Current Deferred Tax Assets jumped 66.81% — and 2014, when it plunged 30.82%.
• A 5-year view of Current Deferred Tax Assets shows it stood at $1.2 billion in 2011, then surged by 33.08% to $1.6 billion in 2012, then rose by 6.51% to $1.7 billion in 2013, then decreased by 3.35% to $1.6 billion in 2014, then rose by 5.29% to $1.7 billion in 2015.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $1.7 billion, $1.9 billion, and $1.9 billion for Q3 2015, Q2 2015, and Q1 2015 respectively.